Arterial Endothelial Cell Generation via Defined Medium
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for deriving arterial endothelial cells from human embryonic stem cells are inefficient and have achieved low results, highlighting a need for scalable and defined methods to generate these cells effectively.
Innovation Solution
A method involving the culture of mesodermal cells in a serum-free, albumin-free, chemically defined medium with specific growth factors such as FGF, VEGF, a Notch agonist, and a TGF-beta inhibitor, which results in a cell population comprising at least 80% arterial endothelial cells expressing specific markers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If existing protocols are used to derive arterial endothelial cells from human embryonic stem cells, then cell differentiation may occur, but the efficiency is very low and results are poor
Solution Approach 1:
The patent applies parameter changes by modifying culture conditions including serum-free medium, albumin-free formulation, chemically defined composition, insulin-free environment, and specific growth factor concentrations to transform the differentiation process from low-efficiency to high-efficiency arterial endothelial cell generation
Solution Approach 2:
The patent uses intermediary substances including FGF, VEGF, Notch agonist, TGF-beta inhibitor, and inositol monophosphatase inhibitor as mediators to facilitate and control the differentiation process from mesodermal cells to arterial endothelial cells, achieving reliable and efficient results
2Quantity of substance
If primary arterial endothelial cells are cultured, then cell expansion is possible, but de-differentiation occurs leading to loss of arterial identity
Solution Approach 1:
The patent maintains continuous exposure to the defined culture medium containing FGF, VEGF, and other factors throughout the culture period, ensuring continuous suppression of de-differentiation while allowing cell expansion, thereby maintaining arterial endothelial cell identity throughout proliferation
Solution Approach 2:
The patent employs culture conditions that provide feedback signaling through growth factors and inhibitors that respond to cell state changes, preventing de-differentiation by maintaining appropriate signaling levels that preserve arterial endothelial cell characteristics during expansion
Data Source
AI summary
Methods for generating human arterial endothelial cells under defined conditions in the absence of insulin are described.